CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- 4 Planned sale Chief Operating Officer sold 37,771 shares at $6.44 ($243,128)
- 4 Planned sale Chief Technology Officer sold 26,250 shares at $6.44 ($168,969)
- 4 Option exercise Director acquired 15,000 shares (option exercise)
- 4 Planned sale Director sold 191 shares at $6.59 ($1,259)
- 4 Planned sale CFO & Treasurer sold 5,704 shares at $5.27 ($30,060)
- 4 Option exercise Director acquired 4,573 shares (option exercise)
- 4 Open-market sale Director sold 1,053 shares at $5.43 ($5,718)
- 4 Planned sale Chief Operating Officer sold 4,932 shares at $5.11 ($25,203)
- 4 Planned sale President and CEO sold 10,808 shares at $5.11 ($55,229)
- 4 Planned sale Chief Regulatory Officer sold 4,483 shares at $5.11 ($22,908)
- 4 Planned sale Chief Technology Officer sold 2,701 shares at $5.11 ($13,802)
- 4 Open-market sale Director sold 3,278 shares at $4.12 ($13,505)
- 4 Open-market sale Chief Medical Officer sold 2,895 shares at $5.96 ($17,254)
- 4 Option exercise Director acquired 4,573 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 20 · 383 filings